Volume 25, Number 8—August 2019
Research
Direct Medical Costs of 3 Reportable Travel-Related Infections in Ontario, Canada, 2012–2014
Table 6
Category | Peel region |
Ontario |
||||||
---|---|---|---|---|---|---|---|---|
No. case-patients | Total direct costs, $ | Cost per case-patient, $, mean (range) | Cost per control, $, mean (range) | Attributable cost (95% CI), $ | No. case-patients | Total direct costs, $† | ||
Overall 90-d cost |
318 |
2,058,196 |
6,472 (0–59,358) |
375 (0–42,213) |
6,098 (5,328–6,868) |
1,216 |
7,870,341 |
|
By disease | ||||||||
Hepatitis A | 55 | 306,707 | 5,576 (0–59,358) | 560 (0–42,213) | 5,016 (2,414–7,619) | 300 | 1,672,944 | |
Malaria | 122 | 613,488 | 5,029 (0–38,556) | 471 (0–26,598) | 4,558 (3,557–5,558) | 612 | 3,077,497 | |
Plasmodium vivax | 43 | 230,487 | ND | ND | 4,812 (2,675–6,949) | ND | ND | |
P. falciparum | 59 | 297,106 | ND | ND | 4,743 (3,588–5,898) | ND | ND | |
Other | 20 | 85,895 | ND | ND | 3,463 (1,397–5,528) | ND | ND | |
Enteric fever |
141 |
1,138,002 |
8,071 (0–33,563) |
219 (0–13,824) |
7,852 (6,812–8,893) |
304 |
2,453,566 |
|
Restricted to most relevant costs | ||||||||
Hepatitis A | 55 | 233,771 | 4,250 (0–23,048) | 266 (0–10,163) | 3,984 (2,823–5,145) | 300 | 1,275,117 | |
Malaria | 122 | 611,030 | 5,008 (0–37,335) | 361 (0–17,626) | 4,647 (3,593–5,701) | 612 | 3,065,171 | |
Enteric fever | 141 | 1,029,311 | 7,300 (0–33,563) | 211 (0–13,824) | 7,089 (6,097–8,081) | 304 | 2,219,224 |
*Cost given in 2015 Canadian dollars. Attributable cost indicates the additional cost for each case-patient. ND, not determined.
†Extrapolated by multiplying the number of cases in the province reported to Public Health Ontario for the same period by the mean cost per case-patient estimated by using Peel region data.
Page created: July 15, 2019
Page updated: July 15, 2019
Page reviewed: July 15, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.